Cargando…

Higher Sensitivity and Earlier Identification of Celiac Disease Autoimmunity by a Nonradioactive Assay for Transglutaminase Autoantibodies

Higher sensitive transglutaminase autoantibody (TGA) assay will detect the onset of celiac disease (CD) autoimmunity earlier. In developing a nonradioactive assay for TGA, we utilized electrochemiluminescence (ECL) technology and compared it to a high-performance radioimmunoassay (RIA) currently bei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhiyuan, Miao, Dongmei, Waugh, Kathleen, Taki, Iman, Dong, Fran, Liu, Edwin, Rewers, Marian, Liu, Yu, Yu, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239972/ https://www.ncbi.nlm.nih.gov/pubmed/28127566 http://dx.doi.org/10.1155/2016/2904563

Ejemplares similares

Distinguishing Persistent Insulin Autoantibodies With Differential Risk: Nonradioactive Bivalent Proinsulin/Insulin Autoantibody Assay
por: Yu, Liping, et al.
Publicado: (2012)

High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously
por: Gu, Yong, et al.
Publicado: (2019)

Large-Scale Screening in General Population Children for Celiac Disease with a Multiplex Electrochemiluminescence (ECL) Assay
por: He, Ling, et al.
Publicado: (2020)

High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
por: Jia, Xiaofan, et al.
Publicado: (2021)

Methods in nonradioactive detection
Publicado: (1993)

Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease
por: Chen, Xi, et al.
Publicado: (2015)

GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013)

Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2020)

Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity
por: Anjum, Naheed, et al.
Publicado: (2009)

Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes
por: Gu, Yong, et al.
Publicado: (2021)

Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy
por: Nurmi, Rakel, et al.
Publicado: (2021)

Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young
por: Steck, Andrea K., et al.
Publicado: (2011)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009)

In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-Like Receptor 4 and Induces Activation of Monocytes
por: Zanoni, Giovanna, et al.
Publicado: (2006)

Abundance and unique repertoire of plasma cells secreting IgA autoantibodies to transglutaminase 2 in the intestinal lesion of celiac disease
por: Di Niro, Roberto, et al.
Publicado: (2012)

Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population
por: Zhao, Zhiyuan, et al.
Publicado: (2016)

Nonradioactive direct telomerase activity detection using biotin‐labeled primers
por: Wang, Ruiguan, et al.
Publicado: (2021)

Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2023)

Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity
por: Yu, Liping, et al.
Publicado: (2013)

Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes
por: Steck, Andrea K., et al.
Publicado: (2014)

Autoantibodies in the Extraintestinal Manifestations of Celiac Disease
por: Yu, Xuechen B., et al.
Publicado: (2018)

Applications of stable, nonradioactive isotope tracers in in vivo human metabolic research
por: Kim, Il-Young, et al.
Publicado: (2016)

Electrochemiluminescence Assays for Human Islet Autoantibodies
por: Gu, Yong, et al.
Publicado: (2018)

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002)

Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
por: Torsten, Matthias, et al.
Publicado: (2018)

Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
por: Stenman, Satumarja M, et al.
Publicado: (2008)

Autoantibody Frequency in Celiac Disease
por: Caglar, Erkan, et al.
Publicado: (2009)

Vitiligo and Autoantibodies of Celiac Disease
por: Shahmoradi, Zabihollah, et al.
Publicado: (2013)

Biocompatibility, Inflammatory Response, and Recannalization Characteristics of Nonradioactive Resin Microspheres: Histological Findings
por: Bilbao, José I., et al.
Publicado: (2009)

The thrombophilic network of autoantibodies in celiac disease
por: Lerner, Aaron, et al.
Publicado: (2013)

IgA Anti-transglutaminase Autoantibodies at Type 1 Diabetes Onset Are Less Frequent in Adult Patients and Are Associated With a General Celiac-Specific Lower Immune Response in Comparison With Nondiabetic Celiac Patients at Diagnosis
por: Tiberti, Claudio, et al.
Publicado: (2012)

International Symposium on the Feasibility of Aneutronic Power : Review of Searches for Nonradioactive Nonproliferating Nuclear Energy
por: Maglic, Bogdan C, et al.
Publicado: (1988)

Variability of anti-human transglutaminase testing in celiac disease across Mediterranean countries
por: Smarrazzo, Andrea, et al.
Publicado: (2017)

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2
por: du Pré, M. Fleur, et al.
Publicado: (2019)

Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease
por: Kaunisto, Helka, et al.
Publicado: (2022)

Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
por: Iervasi, Erika, et al.
Publicado: (2023)

Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia
por: Liu, Chen, et al.
Publicado: (2015)

Autoantibody binding and unique enzyme-substrate intermediate conformation of human transglutaminase 3
por: Heggelund, Julie Elisabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_edp8a3alcro95ma0nk5221qht9